Literature DB >> 9358472

Cell adhesion: a new target for therapy.

C D Buckley1, D L Simmons.   

Abstract

Intercellular adhesive events are involved in a wide range of biological processes, including pattern formation and morphogenesis during development, immune responses, leukocyte recirculation, wound repair, tumour growth and metastasis. In the multicellular state, signals from cell adhesion molecules, along with those from growth factor and cytokine receptors, provide a range of information to the cell that is integrated to yield a final message, perhaps to maintain the cell cycle (if it is a stem cell) or follow a path towards terminal differentiation. Aberrant cell adhesion plays a key role in many developmental defects, acute and chronic inflammatory disease and cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358472     DOI: 10.1016/S1357-4310(97)01128-3

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  5 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 2.  Adhesion molecules in inflammatory diseases.

Authors:  R González-Amaro; F Díaz-González; F Sánchez-Madrid
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

3.  CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway.

Authors:  W Kasinrerk; N Tokrasinwit; P Phunpae
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

Review 4.  Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

Authors:  I R Beavon
Journal:  Mol Pathol       Date:  1999-08

5.  Induction of PNAd and N-acetylglucosamine 6-O-sulfotransferases 1 and 2 in mouse collagen-induced arthritis.

Authors:  Jiwei Yang; Steven D Rosen; Philip Bendele; Stefan Hemmerich
Journal:  BMC Immunol       Date:  2006-06-13       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.